CLINICAL_TRIALS
trial_result
· 2015-12-15
Clinical Trial Update: Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru [NA]
Summary
The NIAID-sponsored study completed a feasibility assessment for measuring immune activation in foreskin/mucosal tissue among HIV-negative, uncircumcised men wh…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | NA | Status: COMPLETED